A new quantitative approach to the study of anthelminthic drugs, with an evaluation of piperazine hexahydrate, phthalylsulfathiazole, and RO 2-5655/3 in the treatment of Enterobius infection.
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D017229:Enterobiasis; D004757:Enterobius; D006801:Humans; D010123:Oxyuriasis / Q000628:therapy*; D000077489:Piperazine; D010879:Piperazines / Q000627:therapeutic use*; D013432:Sulfathiazoles; D013449:Sulfonamides / Q000627:therapeutic use*
D000871:Anthelmintics; D010879:Piperazines; D013432:Sulfathiazoles; D013449:Sulfonamides; D000077489:Piperazine; C100300:phthalylsulfathiazole
ANTHELMINTICS/therapeutic use; OXYURIASIS/therapy; PIPERAZINES/therapeutic use; SULFONAMIDES/therapeutic use